Delta Capital Management Llc decreased its stake in Anthem Inc (ANTM) by 29.64% based on its latest 2019Q1 regulatory filing with the SEC. Delta Capital Management Llc sold 5,745 shares as the company’s stock declined 15.39% while stock markets rallied. The institutional investor held 13,635 shares of the health care company at the end of 2019Q1, valued at $3.91M, down from 19,380 at the end of the previous reported quarter. Delta Capital Management Llc who had been investing in Anthem Inc for a number of months, seems to be less bullish one the $73.09B market cap company. The stock decreased 0.20% or $0.58 during the last trading session, reaching $284.16. About 813,464 shares traded. Anthem, Inc. (NYSE:ANTM) has risen 11.34% since July 10, 2018 and is uptrending. It has outperformed by 6.91% the S&P500. Some Historical ANTM News: 25/04/2018 - U.S. health insurer Anthem’s quarterly profit rises 30 pct; 22/05/2018 - Football Rumors: Latest On Anthem Debate; 16/03/2018 - Singer Rayko Steps Up To Fight Abuse With Gender Genocide - An Anthem For Women Today; 16/05/2018 - CIGNA: NO FIRM EXPRESSED INTEREST IN BUYING IT POST-ANTHEM DEAL; 24/05/2018 - Trump Says NFL Owners’ Anthem Protest Ban Doesn’t Go Far Enough; 23/05/2018 - Football Rumors: Jets Notes: Anthem, Hackenberg; 23/05/2018 - NFL SAYS IT HAS REACHED NEW POLICY ON NATIONAL ANTHEM PROTESTS, REQUIRING PLAYERS TO STAND AND SHOW RESPECT FOR FLAG; 01/05/2018 - Fitch: Anthem’s Negative Outlook Reflects Elevated Fincl Leverage Ratios; 25/04/2018 - ANTHEM INC ANTM.N FY2018 SHR VIEW $15.12, REV VIEW $91.34 BLN — THOMSON REUTERS l/B/E/S; 15/05/2018 - JANA PARTNERS LLC DISSOLVES SOLE SHARE STAKE IN W W GRAINGER INC

Kidder Stephen W decreased its stake in Abbott Labs (ABT) by 8.39% based on its latest 2019Q1 regulatory filing with the SEC. Kidder Stephen W sold 10,715 shares as the company’s stock rose 2.86% with the market. The institutional investor held 116,924 shares of the major pharmaceuticals company at the end of 2019Q1, valued at $9.35M, down from 127,639 at the end of the previous reported quarter. Kidder Stephen W who had been investing in Abbott Labs for a number of months, seems to be less bullish one the $150.43B market cap company. The stock increased 0.21% or $0.18 during the last trading session, reaching $85.27. About 2.96M shares traded. Abbott Laboratories (NYSE:ABT) has risen 23.36% since July 10, 2018 and is uptrending. It has outperformed by 18.93% the S&P500. Some Historical ABT News: 18/04/2018 - ABBOTT LABORATORIES - FORECASTS NET SPECIFIED ITEMS FOR FULL YEAR 2018 OF APPROXIMATELY $1.57 PER SHARE; 18/04/2018 - Abbott sticks to earlier forecasts, disappoints investors; 17/04/2018 - Abbott’s New Ensure® Max Protein Helps Americans Go for Their #HealthGoals; 06/03/2018 - U.S. FDA SAYS GRANTED APPROVAL OF MASTER SERIES HEART VALVE TO ST JUDE MEDICAL; 18/04/2018 - Abbott Labs, Morgan Stanley, U.S. Bancorp, American Express, Alcoa and Pier 1 Imports are all scheduled to publish their latest earnings updates; 11/04/2018 - Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in; 19/03/2018 - ABBOTT’S MITRACLIP THERAPY FOR PATIENTS W/ MITRAL REGURGITATION; 10/04/2018 - Abbott says NAFTA “had to be updated” due to technology and intellectual property challenges; 31/05/2018 - Abbott Introduces the Afinion™ 2 Analyzer Rapid Test System for Diabetes Management; 18/05/2018 - ABBOTT: WILL LOOK TO ADDRESS MENTAL HEALTH & GUN VIOLENCE

More notable recent Anthem, Inc. (NYSE:ANTM) news were published by: Investorplace.com which released: “7 Stocks to Buy for a Dovish Fed - Investorplace.com” on June 25, 2019, also Seekingalpha.com with their article: “Anthem to reaffirm 2019 EPS guidance in investor meetings - Seeking Alpha” published on June 17, 2019, Businesswire.com published: “Anthem to Hold Conference Call and Webcast to Discuss Second Quarter Results on July 24, 2019 - Business Wire” on July 08, 2019. More interesting news about Anthem, Inc. (NYSE:ANTM) were released by: Businesswire.com and their article: “Anthem Announces Appearance at Upcoming Conference - Business Wire” published on June 12, 2019 as well as Finance.Yahoo.com‘s news article titled: “You Have To Love Anthem, Inc.’s (NYSE:ANTM) Dividend - Yahoo Finance” with publication date: May 20, 2019.

Analysts await Anthem, Inc. (NYSE:ANTM) to report earnings on July, 24. They expect $4.62 EPS, up 8.71% or $0.37 from last year’s $4.25 per share. ANTM’s profit will be $1.19 billion for 15.38 P/E if the $4.62 EPS becomes a reality. After $6.03 actual EPS reported by Anthem, Inc. for the previous quarter, Wall Street now forecasts -23.38% negative EPS growth.

Kidder Stephen W, which manages about $246.22M US Long portfolio, upped its stake in Disney (NYSE:DIS) by 14,389 shares to 31,230 shares, valued at $3.47M in 2019Q1, according to the filing. It also increased its holding in Amazon.Com (NASDAQ:AMZN) by 1,067 shares in the quarter, for a total of 1,654 shares, and has risen its stake in Ipg Photonics (NASDAQ:IPGP).

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on July, 17 before the open. They expect $0.80 EPS, up 9.59% or $0.07 from last year’s $0.73 per share. ABT’s profit will be $1.41B for 26.65 P/E if the $0.80 EPS becomes a reality. After $0.63 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 26.98% EPS growth.

Since January 30, 2019, it had 1 insider buy, and 1 sale for $12.17 million activity. The insider Stratton John G bought $249,875.